Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01919346
Recruitment Status : Terminated (Based on results from Alexion PROTECT DGF study)
First Posted : August 9, 2013
Last Update Posted : February 27, 2018
Sponsor:
Collaborators:
Alexion Pharmaceuticals
Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party):
Heeger, Peter, M.D.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017